MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The primary purpose of this study is to identify the optimal dose of voriconazole, an anti-fungal drug often used in people undergoing stem cell transplant. An optimal dose level is one level that provides a good blood level (concentration) of voriconazole without too much toxicity.
Epistemonikos ID: b317c5817ce577d758fdc843309ef6a91c70fb7f
First added on: May 12, 2024